BioSpace News Archive

Corcept Therapeutics Incorporated today announced that it has entered into an agreement with Sun Pharmaceutical Industries Limited and related entities (“Sun”) resolving patent litigation related to Korlym.

Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today announced that it will host an upcoming investor day featuring its intravenous (IV)-administered Synthetic viral RNA (vRNA) Immunotherapy Platform, and its recently nominated lead Synthetic vRNA Immunotherapy product candidates, ONCR-021 and ONCR-788.

Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced the hiring of Jeff Weinrich as Head of Global Sales and Chris Parker as Senior Director of Marketing.

UTILITY therapeutics Ltd., a biotechnology company focused on the development and commercialization of two European-approved antibiotics for the treatment of urinary tract infections (UTIs) in the U.S., provided a business update today.

Evotec SE today announced that its shareholders approved all proposals the Company’s Management put to vote at the Company’s virtual Annual General Meeting 2021.

ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. announced the anticipated closing of their previously announced merger to be effective after the close of the market, June 15, 2021.

Hugel America, Inc., a growth focused joint venture between aesthetic market-leading partners Hugel Inc., and Croma-Pharma GmbH, today announced that the Biologics License Application (BLA) for LetibotulinumtoxinA for Injection, to treat moderate to severe glabellar (frown) lines in adult patients has been accepted for review by the U.S. Food and Drug Administration (FDA).

Predictive Health Diagnostics Company, Inc. announced expansion of its sales representatives to meet the increasing physician demand of its specialty diagnostic tests throughout North America.

Inscopix, Inc., a leading neurotechnology company in California that empowers breakthroughs in brain science, announced the publication of the first demonstration of its miniature microscope -based wearable brain imaging device, nVista™, to perform real-time measurements of large-scale neural activity in behaving rhesus macaques.

This update will include progress towards the initiation of the first clinical trial with PCLX-001 in the next month.